양성 및 악성 타액선 근상피종: 증례보고 및 면역조직화학적 연구

BENIGN AND MALIGNANT MYOEPITHELIOMAS IN SALIVARY GLAND: CASES REPORT AND IMMUNOHISTOCHEMICAL STUDY

  • 변준호 (경상대학교 의학전문대학원 치과학교실 구강악안면외과, 경상대학교 건강과학연구원) ;
  • 이종실 (경상대학교 의학전문대학원 병리학교실) ;
  • 김종렬 (부산대학교 치의학전문대학원 구강악안면외과학교실) ;
  • 박봉욱 (경상대학교 의학전문대학원 치과학교실 구강악안면외과, 경상대학교 건강과학연구원)
  • Byun, June-Ho (Department of Oral and Maxillofacial Surgery, School of Medicine and Institute of Health Science, Gyeongsang National University) ;
  • Lee, Jong-Sil (Department of Pathology, School of Medicine, Gyeongsang National University) ;
  • Kim, Jong-Ryoul (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Park, Bong-Wook (Department of Oral and Maxillofacial Surgery, School of Medicine and Institute of Health Science, Gyeongsang National University)
  • 발행 : 2009.01.31

초록

Benign myoepithelioma (BME) and malignant myoepithelioma (MME) of the salivary gland are very rare and its biologic behavior has not been clarified fully. Although, cases reports for BME and MME were increased in recent, their diagnostic criteria were not completely established. We describe herein a case of BME of the parotid gland and a case of MME of the palatal minor gland, respectively. Histologically, multinodular growth pattern, infiltration to adjacent tissues, and hyalinized and myxoid matrix were observed in MME, that were different histologic features compared with BME. Strong immunoreactivities for the S-100 protein and vimentin were detected in the tumor cells of BME and MME. In specimen of MME, moderately expressed p53 and strongly expressed p63 were detected. However, in specimen of BME, p53 was negatively and p63 was weakly expressed, respectively. In conclusion, the expression patterns of p53 and p63 as well as histologic aggressiveness might be used to diagnose the MME.

키워드

참고문헌

  1. Lee KY, Min KI, Lee JH et al: Myoepithelioma on palate. J Kor Oral Maxillofac Surg 27: 83, 2001
  2. Yoon JH, Ahn SG, Jeong MJ et al: Myoepithelioma of the palate. J Kor Assoc Maxillofac Plast Reconstr Surg 25: 591, 2003
  3. Kawashima Y, Kobayashi D, Ishikawa N et al: A case of myoepithelioma arising in an accessory parotid gland. J Laryngol Otol 116 : 474, 2002
  4. Testa D, Galera F, Insabato L et al: Submandibular gland myoepithelioma. Acta Oto-Laryngologica 125: 664, 2005 https://doi.org/10.1080/00016480510026926
  5. Nagao T, Sugano I, Ishida Y et al : Salivary gland malignant myoepithelioma. A clinicopathologic and immunohistochemical study of ten cases. Cancer 83: 1292, 1998 https://doi.org/10.1002/(SICI)1097-0142(19981001)83:7<1292::AID-CNCR4>3.0.CO;2-L
  6. Savera AT, Sloman A, Huvos AG et al: Myoepithelial carcinoma of the salivary glands. A clinicopathologic study of 25 patients. Am J Surg Pathol 24: 761, 2000 https://doi.org/10.1097/00000478-200006000-00001
  7. Sheldon WH : So-called mixed tumors of the salivary glands. Arch Pathol 35: 1, 1943
  8. Barnes L, Appel BN, Perez H et al: Myoepithelioma of the head and neck: case report and review. J Surg Oncol 28 : 21, 1985 https://doi.org/10.1002/jso.2930280107
  9. Sciubba JJ, Brannon RB: Myoepithelioma of salivary glands : report of 23 cases. Cancer 49: 562, 1982 https://doi.org/10.1002/1097-0142(19820201)49:3<562::AID-CNCR2820490328>3.0.CO;2-6
  10. Dardick I, Thomas MJ, van Nostrand AW : Myoepithelioma-new concepts of histology and classification : a high and electron microscopic study. Ultrastruct Pathol 13: 187, 1989 https://doi.org/10.3109/01913128909057442
  11. Dardick I: Myoepitheliomas. Definitions and diagnostic criteria. Ultrastruct Pathol 19: 359, 1995
  12. Seifert G, Sobin LH: The World Health Organization’s histological classification of salivary gland tumors. A commentary on the second edition. Cancer 70: 379, 1992 https://doi.org/10.1002/1097-0142(19920715)70:2<379::AID-CNCR2820700202>3.0.CO;2-C
  13. Alos L, Cardesa A, Bombi JA et al: Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical, ultrastructural, and flow cytometric study. Semin Diagn Pathol 13: 138, 1996
  14. Herrera GA: Light microscopic, ultrastructural and immunocytochemical spectrum of malignant lacrimal and salivary gland tumors, including malignant mixed tumors. Pathobiology 58: 312, 1990 https://doi.org/10.1159/000163603
  15. Kim KW, Han SJ : Epithelial-myoepithelial carcinoma arising in pleomorphic adenoma of palate. J Kor Oral Maxillofac Surg 33: 479, 2007
  16. Bombi JA, Alos L, Rey MJ et al: Myoepithelial carcinoma arising in a benign myoepithelioma: immunohistochemical, ultrastuctural, and flow-cytometric study. Ultrastruct Pathol 20: 145, 1996 https://doi.org/10.3109/01913129609016309
  17. Seifert G: Histopathology of malignant salivary gland tumors. Oral Oncol Eur J Cancer 28B: 49, 1992 https://doi.org/10.1016/0964-1955(92)90013-Q
  18. Furuse C, Machado de Sousa SO, Nunes FD et al: Myoepithelial cell markers in salivary gland neoplasms. Int J Surg Pathol 13: 57, 2005 https://doi.org/10.1177/106689690501300108
  19. Barbareschi M, Pecciarini L, Cangi MG et al: p63, a p53 Homologue, Is a selective nuclear marker of myoepithelial cells of human breast. Am J Surg Pathol 25: 1054, 2001 https://doi.org/10.1097/00000478-200108000-00010
  20. Ribeiro-Silva A, Ramalho LNZ, Garcia AB et al: p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinoma: further evidence for the pathogenesis of the basal phenotype of breast cancer. Histopathology 47: 458, 2005 https://doi.org/10.1111/j.1365-2559.2005.02249.x